0001168404-17-000018.txt : 20170731 0001168404-17-000018.hdr.sgml : 20170731 20170731120609 ACCESSION NUMBER: 0001168404-17-000018 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170731 DATE AS OF CHANGE: 20170731 EFFECTIVENESS DATE: 20170731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cadence Neuroscience, Inc. CENTRAL INDEX KEY: 0001712390 IRS NUMBER: 815004284 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-291788 FILM NUMBER: 17992094 BUSINESS ADDRESS: STREET 1: 2036 223RD PLACE NE CITY: SAMMAMISH STATE: WA ZIP: 98074 BUSINESS PHONE: 425-681-6863 MAIL ADDRESS: STREET 1: 2036 223RD PLACE NE CITY: SAMMAMISH STATE: WA ZIP: 98074 D 1 primary_doc.xml X0708 D LIVE 0001712390 Cadence Neuroscience, Inc. 2036 223RD PLACE NE SAMMAMISH WA WASHINGTON 98074 425-681-6863 DELAWARE None None Corporation true 2017 Kent Leyde c/o Cadence Neuroscience, Inc. 2036 223rd Pl NE Sammamish WA WASHINGTON 98074 Executive Officer Director Promoter Warren Douglas Sheffield c/o Cadence Neuroscience, Inc. 2036 223rd Pl NE Sammamish WA WASHINGTON 98074 Executive Officer Director Promoter Biotechnology Decline to Disclose 06b false 2017-07-14 false true false 0 Indefinite 0 Indefinite Equity is being issued in consideration of the recipient's performance of certain obligations to the issuer. false 1 0 0 0 false Cadence Neuroscience, Inc. /s/ Kent Leyde Kent Leyde President and CEO 2017-07-31